Scancell Holdings plc (LON:SCLP – Get Free Report) was up 29.8% during mid-day trading on Monday . The stock traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.14). Approximately 10,537,342 shares changed hands during mid-day trading, an increase of 1,073% from the average daily volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).
Scancell Price Performance
The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock has a 50 day moving average of GBX 8.43 and a 200-day moving average of GBX 10.88. The company has a market cap of £113.93 million, a PE ratio of -16.86 and a beta of 0.35.
Scancell (LON:SCLP – Get Free Report) last released its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. Equities analysts predict that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.
About Scancell
Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
See Also
- Five stocks we like better than Scancell
- How to Invest in Small Cap Stocks
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Pros And Cons Of Monthly Dividend Stocks
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What is the Nikkei 225 index?
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
